JP Morgan Chase’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-27,184
| Closed | -$447K | – | 8091 |
|
|
2023
Q4 | $447K | Buy |
27,184
+5,774
| +27% | +$90.9K | ﹤0.01% | 4871 |
|
|
2023
Q3 | $166K | Sell |
21,410
-12,009
| -36% | -$65.1K | ﹤0.01% | 5180 |
|
|
2023
Q2 | $173K | Sell |
33,419
-14,806
| -31% | -$75.5K | ﹤0.01% | 5160 |
|
|
2023
Q1 | $259K | Buy |
48,225
+26,508
| +122% | +$144K | ﹤0.01% | 4901 |
|
|
2022
Q4 | $81K | Sell |
21,717
-538
| -2% | -$2.38K | ﹤0.01% | 5439 |
|
|
2022
Q3 | $111K | Sell |
22,255
-137,406
| -86% | -$765K | ﹤0.01% | 5243 |
|
|
2022
Q2 | $933K | Sell |
159,661
-10,575
| -6% | -$59.7K | ﹤0.01% | 4148 |
|
|
2022
Q1 | $1.21M | Sell |
170,236
-14,127
| -8% | -$138K | ﹤0.01% | 4132 |
|
|
2021
Q4 | $2.43M | Sell |
184,363
-137,404
| -43% | -$2.27M | ﹤0.01% | 3708 |
|
|
2021
Q3 | $7.4M | Sell |
321,767
-162,019
| -33% | -$4.82M | ﹤0.01% | 2686 |
|
|
2021
Q2 | $21.2M | Buy |
483,786
+20,533
| +4% | +$1.14M | ﹤0.01% | 1786 |
|
|
2021
Q1 | $33.6M | Buy |
463,253
+99,027
| +27% | +$7.03M | ﹤0.01% | 1374 |
|
|
2020
Q4 | $15.7M | Buy |
364,226
+81,260
| +29% | +$3.64M | ﹤0.01% | 1822 |
|
|
2020
Q3 | $11.8M | Buy |
282,966
+108,080
| +62% | +$5.59M | ﹤0.01% | 1912 |
|
|
2020
Q2 | $10.5M | Buy |
174,886
+131,937
| +307% | +$12.1M | ﹤0.01% | 1860 |
|
|
2020
Q1 | $3.23M | Sell |
42,949
-103,650
| -71% | -$11.9M | ﹤0.01% | 2603 |
|
|
2019
Q4 | $20.2M | Buy |
+146,599
| New | +$17.8M | ﹤0.01% | 1585 |
|
|
2019
Q2 | – | Sell |
-3
| Closed | -$1K | – | 6079 |
|
|
2019
Q1 | $1K | Buy |
+3
| New | +$451 | ﹤0.01% | 5703 |
|
JP Morgan Chase's ORTX Position: Q1 2024 in Review
JP Morgan Chase sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 27,184 shares — an estimated $447K sold.
JP Morgan Chase first reported a position in ORTX in Q1 2019 and held it in 18 quarters. The position peaked at $33.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- JP Morgan Chase reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- JP Morgan Chase sold 27,184 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $447K.
- JP Morgan Chase first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 18 quarters.
- JP Morgan Chase's Orchard Therapeutics plc American Depositary Shares position peaked at $33.6M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.